Griffin Asset Management, Inc. Fulgent Genetics, Inc. Transaction History

Griffin Asset Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 19, 2022	SELL	$37.92 - $63.74 $22,752 - $38,244	-600 Reduced 10.19%	5,289 $202,000
Q1 2022 Apr 12, 2022	SELL	$49.85 - $96.11 $4,985 - $9,611	-100 Reduced 1.67%	5,889 $368,000
Q4 2021 Jan 28, 2022	BUY	$77.3 - $105.0 $14,687 - $19,950	190 Added 3.28%	5,989 $602,000
Q3 2021 Nov 05, 2021	SELL	$74.87 - $110.87 $188,747 - $279,503	-2,521 Reduced 30.3%	5,799 $522,000
Q2 2021 Jul 28, 2021	SELL	$66.8 - $100.45 $394,988 - $593,960	-5,913 Reduced 41.54%	8,320 $767,000
Q1 2021 May 04, 2021	BUY	$59.3 - $183.85 $844,016 - $2.62 Million	14,233 New	14,233 $1.38 Million

207

17.1M

2.36M

47.9K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $468M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Griffin Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Griffin Asset Management, Inc. with notifications on news.